Cleveland Clinic Cancer Advances
YES1 Inhibitors: A Game-Changer in Triple-Negative Breast Cancer Treatment
October 19, 2023
Ruth Keri, PhD, Associate Director for Basic Research at the Case Comprehensive Cancer Center and Professor of Cancer Biology at Cleveland Clinic, joins the Cancer Advances Podcast to talk about her research on a promising new target for treating triple-n
A Cleveland Clinic podcast for medical professionals exploring the latest innovative research and clinical advances in the field of oncology.
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast